GVHD prophylaxis made safe, easy, and inexpensive
In this issue of Blood, Kanakry and coworkers report on the use of posttransplant cyclophosphamide (Cy) as sole immunoprophylaxis against graft-versus-host disease (GVHD) in HLA-matched related or unrelated allogeneic hematopoietic stem cell transplant (HSCT).
Gespeichert in:
| Veröffentlicht in: | Blood 2014-12, Vol.124 (25), p.3672-3673 |
|---|---|
| 1. Verfasser: | |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 3673 |
|---|---|
| container_issue | 25 |
| container_start_page | 3672 |
| container_title | Blood |
| container_volume | 124 |
| creator | Ringden, O |
| description | In this issue of Blood, Kanakry and coworkers report on the use of posttransplant cyclophosphamide (Cy) as sole immunoprophylaxis against graft-versus-host disease (GVHD) in HLA-matched related or unrelated allogeneic hematopoietic stem cell transplant (HSCT). |
| doi_str_mv | 10.1182/blood-2014-10-607879 |
| format | Article |
| fullrecord | <record><control><sourceid>pubmed_swepu</sourceid><recordid>TN_cdi_swepub_primary_oai_swepub_ki_se_516921</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0006497120395744</els_id><sourcerecordid>25498453</sourcerecordid><originalsourceid>FETCH-LOGICAL-c496t-ba2e12c46b5b322a1b390e4df795427241c8790e8c241c42d11c8975a14532ac3</originalsourceid><addsrcrecordid>eNp9kMFOwzAMhiMEYmPwBgj1ARaI06RtLkhowIY0iQtwjdLEE4FtrZoxtrcnpWOc4BTL-j_H_gg5B3YJUPCrcl5VjnIGggKjGcuLXB2QPkheUMY4OyR9xlhGhcqhR05CeGMxm3J5THpcClUImfYJjF8mt0ndVPXrdm42PiQL4zAJZobDBE3YDhOzdIlf4qbGZfBrPCVHMzMPeLZ7B-T5_u5pNKHTx_HD6GZKrVDZipaGI3ArslKWKecGylQxFG6WKyl4zgXYuDDDwral4A5iQ-XSQNyLG5sOCO3mhk-sP0pdN35hmq2ujNe71nusUEvIFIeYV3_m433uF_oBIWWCF0qyyIqOtU0VQoOzPQ1Mt7b1t23d2m5bne2IXXRYnLtAt4d-9MbAdRfAKGrtsdHBelxadL5Bu9Ku8v__8AVFfJA7</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>GVHD prophylaxis made safe, easy, and inexpensive</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Ringden, O</creator><creatorcontrib>Ringden, O</creatorcontrib><description>In this issue of Blood, Kanakry and coworkers report on the use of posttransplant cyclophosphamide (Cy) as sole immunoprophylaxis against graft-versus-host disease (GVHD) in HLA-matched related or unrelated allogeneic hematopoietic stem cell transplant (HSCT).</description><identifier>ISSN: 0006-4971</identifier><identifier>ISSN: 1528-0020</identifier><identifier>EISSN: 1528-0020</identifier><identifier>DOI: 10.1182/blood-2014-10-607879</identifier><identifier>PMID: 25498453</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Bone Marrow Transplantation - methods ; Cyclophosphamide - therapeutic use ; Female ; Graft vs Host Disease - prevention & control ; Humans ; Leukemia, Myeloid - therapy ; Male ; Medicin och hälsovetenskap ; Myelodysplastic Syndromes - therapy ; Precursor Cell Lymphoblastic Leukemia-Lymphoma - therapy</subject><ispartof>Blood, 2014-12, Vol.124 (25), p.3672-3673</ispartof><rights>2014 American Society of Hematology</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c496t-ba2e12c46b5b322a1b390e4df795427241c8790e8c241c42d11c8975a14532ac3</citedby><cites>FETCH-LOGICAL-c496t-ba2e12c46b5b322a1b390e4df795427241c8790e8c241c42d11c8975a14532ac3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27923,27924</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25498453$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttp://kipublications.ki.se/Default.aspx?queryparsed=id:130428950$$DView record from Swedish Publication Index$$Hfree_for_read</backlink></links><search><creatorcontrib>Ringden, O</creatorcontrib><title>GVHD prophylaxis made safe, easy, and inexpensive</title><title>Blood</title><addtitle>Blood</addtitle><description>In this issue of Blood, Kanakry and coworkers report on the use of posttransplant cyclophosphamide (Cy) as sole immunoprophylaxis against graft-versus-host disease (GVHD) in HLA-matched related or unrelated allogeneic hematopoietic stem cell transplant (HSCT).</description><subject>Bone Marrow Transplantation - methods</subject><subject>Cyclophosphamide - therapeutic use</subject><subject>Female</subject><subject>Graft vs Host Disease - prevention & control</subject><subject>Humans</subject><subject>Leukemia, Myeloid - therapy</subject><subject>Male</subject><subject>Medicin och hälsovetenskap</subject><subject>Myelodysplastic Syndromes - therapy</subject><subject>Precursor Cell Lymphoblastic Leukemia-Lymphoma - therapy</subject><issn>0006-4971</issn><issn>1528-0020</issn><issn>1528-0020</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kMFOwzAMhiMEYmPwBgj1ARaI06RtLkhowIY0iQtwjdLEE4FtrZoxtrcnpWOc4BTL-j_H_gg5B3YJUPCrcl5VjnIGggKjGcuLXB2QPkheUMY4OyR9xlhGhcqhR05CeGMxm3J5THpcClUImfYJjF8mt0ndVPXrdm42PiQL4zAJZobDBE3YDhOzdIlf4qbGZfBrPCVHMzMPeLZ7B-T5_u5pNKHTx_HD6GZKrVDZipaGI3ArslKWKecGylQxFG6WKyl4zgXYuDDDwral4A5iQ-XSQNyLG5sOCO3mhk-sP0pdN35hmq2ujNe71nusUEvIFIeYV3_m433uF_oBIWWCF0qyyIqOtU0VQoOzPQ1Mt7b1t23d2m5bne2IXXRYnLtAt4d-9MbAdRfAKGrtsdHBelxadL5Bu9Ku8v__8AVFfJA7</recordid><startdate>20141211</startdate><enddate>20141211</enddate><creator>Ringden, O</creator><general>Elsevier Inc</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>ADTPV</scope><scope>AOWAS</scope><scope>BTSUP</scope></search><sort><creationdate>20141211</creationdate><title>GVHD prophylaxis made safe, easy, and inexpensive</title><author>Ringden, O</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c496t-ba2e12c46b5b322a1b390e4df795427241c8790e8c241c42d11c8975a14532ac3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Bone Marrow Transplantation - methods</topic><topic>Cyclophosphamide - therapeutic use</topic><topic>Female</topic><topic>Graft vs Host Disease - prevention & control</topic><topic>Humans</topic><topic>Leukemia, Myeloid - therapy</topic><topic>Male</topic><topic>Medicin och hälsovetenskap</topic><topic>Myelodysplastic Syndromes - therapy</topic><topic>Precursor Cell Lymphoblastic Leukemia-Lymphoma - therapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ringden, O</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>SwePub</collection><collection>SwePub Articles</collection><collection>SwePub Editorial</collection><jtitle>Blood</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ringden, O</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>GVHD prophylaxis made safe, easy, and inexpensive</atitle><jtitle>Blood</jtitle><addtitle>Blood</addtitle><date>2014-12-11</date><risdate>2014</risdate><volume>124</volume><issue>25</issue><spage>3672</spage><epage>3673</epage><pages>3672-3673</pages><issn>0006-4971</issn><issn>1528-0020</issn><eissn>1528-0020</eissn><abstract>In this issue of Blood, Kanakry and coworkers report on the use of posttransplant cyclophosphamide (Cy) as sole immunoprophylaxis against graft-versus-host disease (GVHD) in HLA-matched related or unrelated allogeneic hematopoietic stem cell transplant (HSCT).</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>25498453</pmid><doi>10.1182/blood-2014-10-607879</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0006-4971 |
| ispartof | Blood, 2014-12, Vol.124 (25), p.3672-3673 |
| issn | 0006-4971 1528-0020 1528-0020 |
| language | eng |
| recordid | cdi_swepub_primary_oai_swepub_ki_se_516921 |
| source | MEDLINE; EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection |
| subjects | Bone Marrow Transplantation - methods Cyclophosphamide - therapeutic use Female Graft vs Host Disease - prevention & control Humans Leukemia, Myeloid - therapy Male Medicin och hälsovetenskap Myelodysplastic Syndromes - therapy Precursor Cell Lymphoblastic Leukemia-Lymphoma - therapy |
| title | GVHD prophylaxis made safe, easy, and inexpensive |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T14%3A16%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_swepu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=GVHD%20prophylaxis%20made%20safe,%20easy,%20and%20inexpensive&rft.jtitle=Blood&rft.au=Ringden,%20O&rft.date=2014-12-11&rft.volume=124&rft.issue=25&rft.spage=3672&rft.epage=3673&rft.pages=3672-3673&rft.issn=0006-4971&rft.eissn=1528-0020&rft_id=info:doi/10.1182/blood-2014-10-607879&rft_dat=%3Cpubmed_swepu%3E25498453%3C/pubmed_swepu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/25498453&rft_els_id=S0006497120395744&rfr_iscdi=true |